Combined Elevation of FVIII and von Willebrand Factor Predicts Risk for Worse Outcomes in Patients with Acute Ischemic Stroke (AIS) (P7.152)

CONCLUSIONS:Concurrent elevation in FVIII and vWF predicts higher odds of worse outcomes for AIS patients. Our findings suggest that FVIII and vWF levels may serve as clinically useful stroke biomarkers by providing risk profiles for stroke patients on admission with a hypercoagulable state.Disclosure: Dr. Samai has nothing to disclose. Dr. Monlezun, Jr has nothing to disclose. Dr. George has received research support from Tulane University School of Medicine. Dr. Dowell has nothing to disclose. Dr. Schluter has nothing to disclose. Dr. El Khoury has nothing to disclose. Dr. Martin-Schild has nothing to disclose.

Source: Neurology - April 9, 2014 Category: Neurology Authors: Samai, A., Monlezun, D., George, A., Dowell, L., Schluter, L., El Khoury, R., Martin-Schild, S. Tags: Cerebrovascular Disease and Interventional Neurology: Predictors of Outcome After Ischemic Stroke Source Type: research